HomeFUNDING
FUNDING
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
Carlsmed Raises $2.5M to Improve Complex Spine Surgery
The round was led by Cove Fund II, a prominent California Life Science and Technology fund. Participating in the round are MedTech funds Wavemaker Three-Sixty Health and Device of Tomorrow Capital, as well as individual MedTech investors.
Foldax Closes $20 Million Financing
MemorialCare Innovation Fund led the round, with Angel Physicians Fund and Sayan Bioventures joining as new investors.
Puzzle Medical Devices Inc. Announces the Closing of a First Financing Round: Funds to Support Clinical Testing of the Transcatheter Pump
"The accomplishments achieved by Puzzle Medical Devices Inc. in such a short period of time are remarkable," stated Pascal Labrecque. "It already has international support from pioneering interventional cardiologists, on top of an ever-growing IP portfolio. We are enthusiastic about its competent team and bright future."
GlySens Incorporated Closes Incremental $15 Million Financing
Proceeds from the financing will support ongoing clinical trials and development programs supporting the Company's fully implanted, long-term CGM systems and additionally, enable first-in-man studies of the third-generation system.
CytoSorbents Awarded $2,897,172 Phase III STTR Contract
This follows the successful completion of Phase I and II STTR contracts of approximately $1.15 million with researchers at Penn State University, previously funded by the U.S. Army Medical Research Acquisition Activity (USAMRAA) and the U.S. Army Medical Research and Material Command (USAMRMC).
HistoSonics Announces $40 Million Financing
HistoSonics notes the breakthrough medical platform offers vision of non-invasive procedures to eliminate diseased tissues and tumors
Alpha Tau Medical Announces Successful Completion of New $26 Million Funding Round
During the last year, Alpha Tau Medical successfully completed its first-in-human clinical trial of Alpha DaRT with squamous cell carcinoma patients from Italy and Israel.
Base Genomics Announces Company Launch and Raises $11 Million USD
Base Genomics is led by a highly experienced team of scientists and clinicians, including Dr Vincent Smith, a world-leader in genomic product development and other prominent leaders.
LaunchPad Medical Wins a Coveted $1.8 Million Michigan-Pittsburgh-Wyss Regenerative Medicine Center Grant
This grant, the largest it has received from the Resource Center, will allow the company to conduct a pivotal animal study and generate all the other required data to file an Investigational Device Exemption (IDE) application with the FDA to start a clinical trial.
